AIM
CDNA icon

ARK Investment Management’s CareDx CDNA Stock Holding History

ARK Investment Management’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.7M Sell
1,953,531
-274,025
-12% -$5.97M 0.36% 55
2026
Q1 		$38.7M Buy
2,227,556
+91,153
+4% +$1.73M 0.3% 60
2025
Q4 		$40.2M Sell
2,136,403
-34,222
-2% -$573K 0.27% 62
2025
Q3 		$31.6M Buy
2,170,625
+70,468
+3% +$1M 0.19% 72
2025
Q2 		$41M Sell
2,100,157
-247,225
-11% -$4.39M 0.3% 52
2025
Q1 		$41.7M Sell
2,347,382
-61,718
-3% -$1.33M 0.42% 44
2024
Q4 		$51.6M Sell
2,409,100
-579,497
-19% -$14.1M 0.43% 40
2024
Q3 		$93.3M Sell
2,988,597
-2,713,754
-48% -$67.5M 0.85% 28
2024
Q2 		$88.6M Sell
5,702,351
-161,695
-3% -$1.95M 0.79% 30
2024
Q1 		$62.1M Sell
5,864,046
-1,330,676
-18% -$13.3M 0.43% 40
2023
Q4 		$86.3M Buy
7,194,722
+515,399
+8% +$4.22M 0.51% 37
2023
Q3 		$46.8M Buy
6,679,323
+40,973
+0.6% +$379K 0.36% 42
2023
Q2 		$56.4M Sell
6,638,350
-161,089
-2% -$1.34M 0.37% 38
2023
Q1 		$62.1M Buy
6,799,439
+611,257
+10% +$7.82M 0.43% 38
2022
Q4 		$70.6M Buy
6,188,182
+401,062
+7% +$5.94M 0.61% 32
2022
Q3 		$98.5M Buy
5,787,120
+1,791,670
+45% +$38.5M 0.69% 30
2022
Q2 		$100M Buy
3,995,450
+484,216
+14% +$13.4M 0.59% 35
2022
Q1 		$130M Sell
3,511,234
-127,540
-4% -$4.97M 0.54% 35
2021
Q4 		$165M Buy
3,638,774
+228,621
+7% +$11.9M 0.5% 41
2021
Q3 		$216M Sell
3,410,153
-1,153,957
-25% -$87.9M 0.52% 44
2021
Q2 		$418M Buy
4,564,110
+103,286
+2% +$8.21M 0.78% 34
2021
Q1 		$304M Buy
4,460,824
+398,502
+10% +$30.9M 0.6% 48
2020
Q4 		$294M Buy
4,062,322
+2,203,095
+118% +$128M 0.78% 38
2020
Q3 		$70.5M Buy
1,859,227
+583,725
+46% +$19.7M 0.42% 51
2020
Q2 		$45.2M Buy
1,275,502
+487,358
+62% +$13.9M 0.49% 39
2020
Q1 		$17.2M Buy
788,144
+222,706
+39% +$4.99M 0.43% 45
2019
Q4 		$12.2M Buy
565,438
+248,138
+78% +$5.69M 0.31% 50
2019
Q3 		$7.17M Buy
317,300
+189,692
+149% +$5.25M 0.16% 63
2019
Q2 		$4.59M Buy
+127,608
New +$4.08M 0.12% 74

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

ARK Investment Management's CDNA Position: Q2 2026 in Review

ARK Investment Management reduced its CareDx (CDNA) stake by 12% in Q2 2026, selling an estimated $5.97M and leaving 1,953,531 shares worth $55.7M. The position accounts for 0.36% of the portfolio, ranked #55.

ARK Investment Management first reported a position in CDNA in Q2 2019 and has held it in 29 quarters since. The position peaked at $418M in Q2 2021. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • ARK Investment Management held 1,953,531 shares of CareDx worth $55.7M as of Q2 2026.
  • ARK Investment Management sold 274,025 CareDx shares in Q2 2026, an estimated $5.97M.
  • CareDx made up 0.36% of ARK Investment Management's portfolio in Q2 2026, its #55 holding.
  • ARK Investment Management first reported a position in CareDx in Q2 2019 and has held it in 29 quarters since.
  • ARK Investment Management's CareDx position peaked at $418M in Q2 2021.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on ARK Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.